SeaStar Medical tumbles on $10 mln stock offering
** Shares of pharmaceutical firm SeaStar Medical Holding
ICU.O slump 34% to $8.57
** Company to raise nearly $10 mln via stock offering
** Deal priced at $10.55/shr — a 19% discount to ICU's last
close
** Also sells warrants to purchase 947,868 shares
** Company is developing a therapy to reduce consequences of
hyper-inflammation on vital organs
(Reporting by Niket Nishant in Bengaluru)
((Niket.Nishant@thomsonreuters.com))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview